Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Thalidomide in NSCLC
NCT00114192Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Jun 2004
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of thalidomide in non-small cell lung cancer (NSCLC), sponsored by University of Virginia. Primary endpoint: Complete and Partial Response Rates. Started Jun 2004; status: completed.
02
Drugs
thalidomide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00114192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00114192.